Single Dual Time-point PET Scan Identifies Dual Alzheimer's Biomarkers

While subject No. 1 (left) was judged as positive for both the neuronal injury and the amyloid load biomarker, both Alzheimer's disease biomarkers were negative in subject No. 2 (right). Image courtesy of Henryk Barthel et al., University Hospital Leipzig, Leipzig, Germany


More people die of Alzheimer's disease than prostate and breast cancer combined. Identifying the disease before major symptoms arise is critical to preserving brain function and helping patients maintain quality of life. A new study presented at the 2017 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI) demonstrates that a single dual time-point PET scan could identify important biomarkers of Alzheimer's disease.

The Alzheimer's Association reports that more than 5 million Americans are estimated to be living with Alzheimer's disease. This number is expected to swell as high as 16 million by 2050, when Alzheimer's and other dementias could cost the U.S. more than $1 trillion.

For this study, researchers assessed a procedure called dual time-point fluorine-18 Florbetaben (18F-FBB) PET imaging, which involves the injection of a single radiotracer, 18F-FBB, and two scans performed to observe blood flow and amyloid burden in the brain--two biomarkers for neurodegenerative disease, including Alzheimer's.

"Until now, researchers conducted two separate molecular imaging procedures to glean information about beta-amyloid buildup and neuronal injury in the brain," said Henryk Barthel, M.D., Ph.D., from the department of nuclear medicine, University Hospital Leipzig, in Leipzig, Germany. "This study provides proof-of-concept that information about both biomarkers can be obtained from the administration of a single PET tracer."

The study examined 112 subjects (ages 62-82, with 53 women), 41 diagnosed with mild cognitive impairment, 50 with probable or possible Alzheimer's and 21 with another dementia. Dual time-point 18F-FBB PET scans were conducted during the first 10 minutes of the procedure and again from the 90-to-110-minute mark. Researchers performed quantitative and visual analyses of PET data. With this data, they were able to determine both neuronal injury and amyloid load in all subjects. At least one biomarker was positive in 39 percent of the subjects with mild cognitive impairment, in 37 percent of patients with possible Alzheimer's dementia, and in 72 percent of patients with probable Alzheimer's dementia.

Larger prospective trials are needed to further validate this research, but if these results continue, dual time-point 18F-FBB PET could supplement diagnostic dementia workups by providing essential information about Alzheimer's pathology in a convenient and clinically useful manner.

For more information: www.snmmi.org


Related Content

News | Nuclear Imaging

June 20, 2024 — GE HealthCare joined the world’s top medical and academic institutions at the Society of Nuclear ...

Time June 20, 2024
arrow
News | Proton Therapy

June 14, 2024 — Atlantic Health System, an integrated health care system setting standards for quality health care in ...

Time June 14, 2024
arrow
News | PET Imaging

June 14, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 14, 2024
arrow
News | SNMMI

June 13, 2024 — The Society of Nuclear Medicine and Molecular Imaging (SNMMI) hosted more than 8,000 physicians ...

Time June 13, 2024
arrow
News | PET-CT

June 13, 2024 — Positron Corporation, a leading molecular imaging medical device company offering PET and PET-CT ...

Time June 13, 2024
arrow
News | Radiology Business

June 12, 2024 — Cathy Sue Cutler, PhD, FSNMMI, chair of the Isotope Research and Production Department at Brookhaven ...

Time June 12, 2024
arrow
News | SPECT-CT

June 11, 2024 — A newly developed radiotracer can generate high quality and readily interpretable images of cardiac ...

Time June 11, 2024
arrow
News | PET Imaging

June 11, 2024 — A new ultra-high-performance brain PET system allows for the direct measurement of brain nuclei as never ...

Time June 11, 2024
arrow
News | Radiology Business

June 10, 2024 — Jean-Luc C. Urbain, MD, PhD, FASNC, professor of Radiology/Nuclear Medicine and Medicine, has been named ...

Time June 10, 2024
arrow
News | Radiology Business

June 10, 2024 — Carolyn J. Anderson, PhD, a trailblazer in nuclear medicine, has been named the 2024 recipient of the ...

Time June 10, 2024
arrow
Subscribe Now